Gilead Sciences (NASDAQ:GILD) is known for several things. It’s a leader in developing HIV drugs such as Truvada and Genvoya. The company’s drugs Sovaldi, Harvoni, and Epclusa have changed the landscape in treatment of hepatitis C. Gilead is now one of the biggest biotechs in the world.
